MTOR and breast cancer: We identified mTOR signaling, a critical pathway frequently dysregulated in breast cancer and implicated in cell survival and dormancy through its two complementary arms (mTORC1 and mTORC2), as the most significantly activated signaling pathway of ex vivo cells.